Absence of leukotriene B4 receptor 1 confers resistance to airway hyperresponsiveness and Th2-type immune responses

Journal of Immunology

Volumn 175, Issue 7, 2005, Pages 4217-4225

  Terawaki, Kan ^a,b   Yokomizo, Takehiko ^a,b   Nagase, Takahide ^a   Toda, Akiko ^a,b   Taniguchi, Masahiko ^a,b   Hashizume, Kohei ^a   Yagi, Takeshi ^c   Shimizu, Takao ^a,b  

^a UNIVERSITY OF TOKYO   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN E; INTERLEUKIN 13; INTERLEUKIN 5; LEUKOTRIENE B4 RECEPTOR; LEUKOTRIENE B4 RECEPTOR 1; OVALBUMIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTHMA; BRONCHUS HYPERREACTIVITY; BRONCHUS MUCUS; CELL HYPERPLASIA; CHRONIC INFLAMMATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; EOSINOPHIL; FEMALE; GENE EXPRESSION; GOBLET CELL; IMMUNE RESPONSE; IMMUNOGLOBULIN PRODUCTION; IMMUNOSTIMULATION; IN VITRO STUDY; LUNG LAVAGE; LYMPH NODE CELL; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SENSITIZATION; SYMPTOMATOLOGY; TH2 CELL;

EID: 25444447952     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.175.7.4217     Document Type: Article

References (50)

1. Cochrane, G. M. 1990. Bronchial asthma and the role of β2-agonists. Lung 168 (Suppl.): 66-70.
2. Bardana, E. J., Jr. 2002. Airway hyperreactivity: managing outcomes and new directions. Allergy Asthma Proc. 23: 367-371.
3. Sheth, K. K., and R. F. Lemanske, Jr. 1991. Pathogenesis of asthma. Pediatrician 18: 257-268.
4. Foster, P. S., S. P. Hogan, A. J. Ramsay, K. I. Matthaei, and I. G. Young. 1996. Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model. J. Exp. Med. 183: 195-201.
5. Wolyniec, W. W., G. T. De Sanctis, G. Nabozny, C. Torcellini, N. Haynes, A. Joetham, E. W. Gelfand, J. M. Drazen, and T. C. Noonan. 1998. Reduction of antigen-induced airway hyperreactivity and eosinophilia in ICAM-1-deficient mice. Am. J. Respir. Cell. Mol. Biol. 18: 777-785.
6. Hamelmann, E., K. Takeda, J. Schwarze, A. T. Vella, C. G. Irvin, and E. W. Gelfand. 1999. Development of eosinophilic airway inflammation and airway hyperresponsiveness requires interleukin-5 but not immunoglobulin E or B lymphocytes. Am. J. Respir. Cell. Mol. Biol. 21: 480-489.
7. Tomkinson, A., A. Kanehiro, N. Rabinovitch, A. Joetham, G. Cieslewicz, and E. W. Gelfand. 1999. The failure of STAT6-deficient mice to develop airway eosinophilia and airway hyperresponsiveness is overcome by interleukin-5. Am. J. Respir. Crit. Care Med. 160: 1283-1291.
8. Mould, A. W., A. J. Ramsay, K. I. Matthaei, I. G. Young, M. E. Rothenberg, and P. S. Foster. 2000. The effect of IL-5 and eotaxin expression in the lung on eosinophil trafficking and degranulation and the induction of bronchial hyperreactivity. J. Immunol. 164: 2142-2150.
9. Yang, M., S. P. Hogan, P. J. Henry, K. I. Matthaei, A. N. McKenzie, I. G. Young, M. E. Rothenberg, and P. S. Foster. 2001. Interleukin-13 mediates airways hyperreactivity through the IL-4 receptor-α chain and STAT-6 independently of IL-5 and eotaxin. Am. J. Respir. Cell. Mol. Biol. 25: 522-530.
10. Uozumi, N., K. Kume, T. Nagase, N. Nakatani, S. Ishii, F. Tashiro, Y. Komagata, K. Maki, K. Ikuta, Y. Ouchi, J. Miyazaki, and T. Shimizu. 1997. Role of cytosolic phospholipase A2 in allergic response and parturition. Nature 390: 618-622.
11. Matsuoka, T., M. Hirata, H. Tanaka, Y. Takahashi, T. Murata, K. Kabashima, Y. Sugimoto, T. Kobayashi, F. Ushikubi, Y. Aze, et al. 2000. Prostaglandin D2 as a mediator of allergic asthma. Science 287: 2013-2017.
12. Samuelsson, B., S. E. Dahlen, J. A. Lindgren, C. A. Rouzer, and C. N. Serhan. 1987. Leukotrienes and lipoxins: structures, biosynthesis, and biological effects. Science 237: 1171-1176.
13. Lewis, R. A., K. F. Austen, and R. J. Soberman. 1990. Leukotrienes and other products of the 5-lipoxygenase pathway. Biochemistry and relation to pathobiology in human diseases. N. Engl. J. Med. 323: 645-655.
14. Brink, C., S. E. Dahlen, J. Drazen, J. F. Evans, D. W. Hay, S. Nicosia, C. N. Serhan, T. Shimizu, and T. Yokomizo. 2003. International Union of Pharmacology XXXVII. Nomenclature for Leukotriene and Lipoxin Receptors. Pharmacol. Rev. 55: 195-227.
15. Irvin, C. G., Y. P. Tu, J. R. Sheller, and C. D. Funk. 1997. 5-Lipoxygenase products are necessary for ovalbumin-induced airway responsiveness in mice. Am. J. Physiol 272: L1053-L1058.
16. Leick-Maldonado, E. A., F. U. Kay, M. C. Leonhardt, D. I. Kasahara, C. M. Prado, F. T. Fernandes, M. A. Martins, and I. F. Tiberio. 2004. Comparison of glucocorticoid and cysteinyl leukotriene receptor antagonist treatments in an experimental model of chronic airway inflammation in guinea-pigs. Clin. Exp. Allergy 34: 145-152.
17. Funk, C. D. 2001. Prostaglandins and leukotrienes: advances in eicosanoid biology. Science 294: 1871-1875.
18. 4 that mediates chemotaxis. Nature 387: 620-624.
19. 4 receptor, BLT2. A new therapeutic target in inflammation and immunological disorders. J. Exp. Med. 192: 421-432.
20. 4 and BLT1 control cytotoxic effector T cell recruitment to inflamed tissues. Nat. Immunol. 4: 965-973.
21. 4 receptor BLT1 mediates early effector T cell recruitment. Nat. Immunol. 4: 982-990.
22. 4. Nat. Immunol. 4: 974-981.
23. Yagi, T., S. Nada, N. Watanabe, H. Tamemoto, N. Kohmura, Y. Ikawa, and S. Aizawa. 1993. A novel negative selection for homologous recombinants using diphtheria toxin A fragment gene. Anal. Biochem. 214: 77-86.
24. Yagi, T., T. Tokunaga, Y. Furuta, S. Nada, M. Yoshida, T. Tsukada, Y. Saga, N. Takeda, Y. Ikawa, and S. Aizawa. 1993. A novel ES cell line, TT2, with high germline-differentiating potency. Anal. Biochem. 214: 70-76.
25. 4 binding to human neutrophils. Prostaglandins 28: 837-849.
26. Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72: 248-254.
27. 4 receptor site. J. Pharmacol. Exp. Ther. 236: 126-132.
28. 4-induced enzyme release. J. Biol. Chem. 277: 44898-44904.
29. Nagase, T., S. Ishii, K. Kume, N. Uozumi, T. Izumi, Y. Ouchi, and T. Shimizu. 1999. Platelet-activating factor mediates acid-induced lung injury in genetically engineered mice. J. Clin. Invest. 104: 1071-1076.
30. Ishii, S., T. Nagase, H. Shindou, H. Takizawa, Y. Ouchi, and T. Shimizu. 2004. Platelet-activating factor receptor develops airway hyperresponsiveness independently of airway inflammation in a murine asthma model. J. Immunol. 172: 7095-7102.
31. McMillan, S. J., B. Bishop, M. J. Townsend, A. N. McKenzie, and C. M. Lloyd. 2002. The absence of interleukin 9 does not affect the development of allergen-induced pulmonary inflammation nor airway hyperreactivity. J. Exp. Med. 195: 51-57.
32. Humbles, A. A., D. M. Conroy, S. Marleau, S. M. Rankin, R. T. Palframan, A. E. Proudfoot, T. N. Wells, D. Li, P. K. Jeffery, D. A. Griffiths-Johnson, et al. 1997. Kinetics of eotaxin generation and its relationship to eosinophil accumulation in allergic airways disease: analysis in a guinea pig model in vivo. J. Exp. Med. 186: 601-612.
33. 4. Identification of a subset of high affinity receptors that transduce the chemotactic response. J. Exp. Med. 159: 1027-1041.
34. 4 receptors in human mononuclear cells. Life Sci. 68: 2207-2212.
35. 4 receptors in human hematopoietic cells. Immunopharmacology 48: 157-163.
36. 4 receptor expressed on eosinophils. J. Exp. Med. 188: 1063-1074.
37. 4-induced chemotaxis and adhesion and plays a dominant role in eosinophil accumulation in a murine model of peritonitis. J. Exp. Med. 192: 439-446.
38. Lee, J. J., D. Dimina, M. P. Macias, S. I. Ochkur, M. P. McGarry, K. R. O'Neill, C. Protheroe, R. Pero, T. Nguyen, S. A. Cormier, et al. 2004. Defining a link with asthma in mice congenitally deficient in eosinophils. Science 305: 1773-1776.
39. Wills-Karp, M., and C. L. Karp. 2004. Biomedicine. Eosinophils in asthma: remodeling a tangled tale. Science 305: 1726-1729.
40. Humbles, A. A., C. M. Lloyd, S. J. McMillan, D. S. Friend, G. Xanthou, E. E. McKenna, S. Ghiran, N. P. Gerard, C. Yu, S. H. Orkin, and C. Gerard. 2004. A critical role for eosinophils in allergic airways remodeling. Science 305: 1776-1779.
41. Cohn, L., R. J. Homer, A. Marinov, J. Rankin, and K. Bottomly. 1997. Induction of airway mucus production By T helper 2 (Th2) cells: a critical role for interleukin 4 in cell recruitment but not mucus production. J. Exp. Med. 186: 1737-1747.
42. Paul, W. E. 1991. Interleukin-4: a prototypic immunoregulatory lymphokine. Blood 77: 1859-1870.
43. Sanderson, C. J. 1992. Interleukin-5, eosinophils, and disease. Blood 79: 3101-3109.
44. Wills-Karp, M., J. Luyimbazi, X. Xu, B. Schofield, T. Y. Neben, C. L. Karp, and D. D. Donaldson. 1998. Interleukin-13: central mediator of allergic asthma. Science 282: 2258-2261.
45. 4 receptor in mice reveals its role in inflammation and platelet-activating factor-induced anaphylaxis. J. Exp. Med. 192: 433-438.
46. 4 receptor transgenic mice reveal novel protective roles for lipoxins and aspirin-triggered lipoxins in reperfusion. J. Clin. Invest. 104: 309-316.
47. Elias, J. A., C. G. Lee, T. Zheng, Y. Shim, and Z. Zhu. 2003. Interleukin-13 and leukotrienes: an intersection of pathogenetic schema. Am. J. Respir. Cell. Mol. Biol. 28: 401-404.
48. Miyahara, N., B. J. Swanson, K. Takeda, C. Taube, S. Miyahara, T. Kodama, A. Dakhama, V. L. Ott, and E. W. Gelfand. 2004. Effector CD8 + T cells mediate inflammation and airway hyper-responsiveness. Nat. Med. 10: 865-869.
49. 4 receptor-1 in allergen-induced airway hyperresponsiveness. Am. J. Respir. Crit. Care Med. 172: 161-167.
50. + T cells and airway hyperresponsiveness. J. Immunol. 174: 4979-4984.